Statins and cancer prevention

Marie France Demierre, Peter D.R. Higgins, Stephen B. Gruber, Ernest Hawk, Scott M. Lippman

Research output: Contribution to journalReview articlepeer-review

698 Scopus citations

Abstract

Randomized controlled trials for preventing cardiovascular disease indicated that statins had provocative and unexpected benefits for reducing colorectal cancer and melanoma. These findings have led to the intensive study of statins in cancer prevention, including recent, large population-based studies showing statin-associated reductions in overall, colorectal and prostate cancer. Understanding the complex cellular effects (for example, on angiogenesis and inflammation) and the underlying molecular mechanisms of statins (for example, 3-hydroxy-3-methylglutaryl coenzyme-A (HMG-CoA) reductase-dependent processes that involve geranylgeranylation of Rho proteins, and HMG-CoA-independent processes that involve lymphocyte-function-associated antigen 1) will advance the development of molecularly targeted agents for preventing cancer. This understanding might also help the development of drugs for other ageing-related diseases with interrelated molecular pathways.

Original languageEnglish (US)
Pages (from-to)930-942
Number of pages13
JournalNature Reviews Cancer
Volume5
Issue number12
DOIs
StatePublished - Dec 2005
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Statins and cancer prevention'. Together they form a unique fingerprint.

Cite this